Arcadia Biosciences, Inc. (RKDA)

US — Basic Materials Sector
Peers: YGF  BTTR  SNAX  FITSF    BTOG  SMFL  FAMI  LSF  PLAG  PFODF  SENEA  BRID  RIBT 

Automate Your Wheel Strategy on RKDA

With Tiblio's Option Bot, you can configure your own wheel strategy including RKDA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol RKDA
  • Rev/Share 3.8498
  • Book/Share 6.5187
  • PB 0.7348
  • Debt/Equity 0.0024
  • CurrentRatio 3.9919
  • ROIC -0.2231

 

  • MktCap 6548122.0
  • FreeCF/Share -5.8621
  • PFCF -0.8177
  • PE -3.2457
  • Debt/Assets 0.0016
  • DivYield 0
  • ROE -0.2172

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 5
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
RKDA
Published: May 08, 2025 by: GlobeNewsWire
Sentiment: Neutral

-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025.

Read More
image for news Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders
RKDA
Published: February 24, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Roosevelt Resources LP is fair to Arcadia shareholders. Upon closing of the proposed transaction, Arcadia shareholders are expected to own approximately 10% of the combined company. Halper Sadeh encourages Arcadia shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212.

Read More
image for news RKDA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arcadia Biosciences, Inc. is Fair to Shareholders

About Arcadia Biosciences, Inc. (RKDA)

  • IPO Date 2015-05-15
  • Website https://www.arcadiabio.com
  • Industry Agricultural Inputs
  • CEO Mr. Thomas J. Schaefer C.F.A.
  • Employees 9

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.